Our second 2023 seminar – in collaboration with the Medical Device Partnering Program (MDPP)
Featuring guest speakers from Micro-X, MDPP and QUT, participants, alumni and associated networks were invited to this inspiring seminar, offering a deep-dive into innovation in South Australian medtech, including an opportunity to network with likeminded medtech professionals in Tonsley’s Innovation Precinct. Seminar attendees were also kindly invited to join the Innovation Precinct’s Tour.
Chris Delnooz, Software Manager, Micro-X
Chris has over 15 years experience in multi-disciplinary product development across various high-tech sectors such as industrial printing, display graphics, PCB manufacturing, wafer scanning & metrology, and medtech. In in the Netherlands Chris worked as an Embedded Software Architect for Océ Technologies (part of Canon), ASML and Mutrax. After coming to Australia in 2013, as a senior consultant for Hydrix Services, Chris worked for medtech clients such as LBT Innovations and Micro-X. Chris has been involved as Systems Engineer in Micro-X’s Nano program from its early conception to market.
Stephen Blakeney, Innovations Manager, Medical Device Partnering Program
Stephen Blakeney is the National Innovations Manager for the Medical Device Partnering Program, co-lead for Research Translation at the Medical Device Research Institute, a Guest Lecturer and mentor for the Innovation in Medical Device course at Flinders University, his role is co-funded by the Australian National Fabrication Facility, and he is a member of the Bridgetech steering committee. Stephen started his career as a mechanical engineer developing a system to help deliver electrodes to the brain for Deep Brain Stimulation to treat Parkinsons and he has since gone on to work on a wide variety of devices including a liver retractor for laparoscopic surgery, ophthalmic equipment, post-stroke rehabilitation equipment and more. Stephen moved into commercially-focused roles around 6 years ago, including working for the Health and Medical team at the Department for Trade and Investment where he led a delegation of health and life sciences companies on a trade mission to China and helped to support inbound investment of companies into Adelaide. In his current role he supports medical device companies around Australia, speaking to at least 50-100 medtech start-ups per year and providing advice and guidance on how to commercialise their medical devices.
Lyn Griffiths. Director of the QUT Centre for Genomics and Personalised Health, QUT Genomics Research Centre, and the Bridge and BridgeTech Programs.
Distinguished Professor Lyn Griffiths AM is an active and respected molecular geneticist whose research has led to diagnostic breakthroughs for several neurogenetic disorders, including familial migraine, ataxia, epilepsy and hereditary stroke, and has appeared in more than 400 international journals. Her work at the QUT Genomics Research Centre is focused on identifying genes involved in common traits and disorders including migraine, cardiovascular disease risk traits, memory and concussion. For this research she has established a significant bank of population genomics resources including case control, multigenerational pedigree and genetic isolate from (Norfolk Island) cohorts. DProf Griffiths also established and leads the QUT Centre for Genomics and Personalised Health, which aims to discover better methods of diagnosing disease, and to develop targeted treatments based on genetic information. As Director of the MTPConnect and industry-led Bridge and BridgeTech programs, she is a passionate advocate for the translation of research to commercialisation in the pharmaceutical and medical devices-technology fields.
|Location:||Tonsley Innovation Precinct, Flinders University, South Australia.|
|Start Date:||23/05/2023 [add to calendar]|